Monday, December 08, 2003

Antipsychotic Dosing: Individualizing Medication Treatment
A new CME unit from Medscape based on the work of an expert advisory panel "developed in order to use available scientific and clinical evidence to optimize dosing and titration of currently available atypical antipsychotic agents." [Viewing Medscape resources requires registration, which is free].  
  

Scientists Take Inside Look Into Origins of Schizophrenia
Chicago Tribune stopry reprinted at PsycPORT - "Using sophisticated imaging technology that peers deeper into the brain than ever before, scientists reported Tuesday in Chicago that they are beginning to see where schizophrenia begins and possibly what's causing it. The report highlights the speed of discoveries coming from the new field of brain imaging that scientists say is helping them understand mental disorders such as schizophrenia, dyslexia and antisocial behavior."  
  

Attention Deficit Drugs May Have Long-Term Effects
Reuters Health story at Yahoo - "Drugs given to children to treat attention deficit hyperactivity disorder could have long-term effects on their growing brains, studies on rats suggest. Several studies published on Monday show that rats given a popular ADHD drug were less likely to want to use cocaine later in life, but also often acted clinically depressed and behaved differently from rats give dummy injections. ..."